These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11812637)

  • 1. Subacute cytotoxicity testing with cultured human lung cells.
    Yang A; Cardona DL; Barile FA
    Toxicol In Vitro; 2002 Feb; 16(1):33-9. PubMed ID: 11812637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute cytotoxicity testing with cultured human lung and dermal cells.
    Barile FA; Cardona M
    In Vitro Cell Dev Biol Anim; 1998 Sep; 34(8):631-5. PubMed ID: 9769147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro cytotoxicity testing for prediction of acute human toxicity.
    Barile FA; Dierickx PJ; Kristen U
    Cell Biol Toxicol; 1994 Jun; 10(3):155-62. PubMed ID: 7994632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytotoxicity testing: Biological and statistical significance.
    Barile FA; Arjun S; Hopkinson D
    Toxicol In Vitro; 1993 Mar; 7(2):111-6. PubMed ID: 20732178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Registry of Cytotoxicity: toxicity testing in cell cultures to predict acute toxicity (LD50) and to reduce testing in animals.
    Halle W
    Altern Lab Anim; 2003; 31(2):89-198. PubMed ID: 15612878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of ecotoxicological tests.
    Botsford JL
    Altern Lab Anim; 2002; 30(5):539-50. PubMed ID: 12432890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
    O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
    Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refinement and reduction of acute oral toxicity testing: a critical review of the use of cytotoxicity data.
    Schrage A; Hempel K; Schulz M; Kolle SN; van Ravenzwaay B; Landsiedel R
    Altern Lab Anim; 2011 Jul; 39(3):273-95. PubMed ID: 21777041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the predictive capacity of the 3T3 Neutral Red Uptake cytotoxicity test method to identify substances not classified for acute oral toxicity (LD50>2000 mg/kg): results of an ECVAM validation study.
    Prieto P; Cole T; Curren R; Gibson RM; Liebsch M; Raabe H; Tuomainen AM; Whelan M; Kinsner-Ovaskainen A
    Regul Toxicol Pharmacol; 2013 Apr; 65(3):344-65. PubMed ID: 23246604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved method for in vitro assessment of dermal toxicity for volatile organic chemicals.
    Rogers JV; McDougal JN
    Toxicol Lett; 2002 Sep; 135(1-2):125-35. PubMed ID: 12243871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytotoxicity testing with fluorescence-based assays in cultured human lung and dermal cells.
    Yang A; Cardona DL; Barile FA
    Cell Biol Toxicol; 2002; 18(2):97-108. PubMed ID: 12046694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The integrated acute systemic toxicity project (ACuteTox) for the optimisation and validation of alternative in vitro tests.
    Clemedson C; Kolman A; Forsby A
    Altern Lab Anim; 2007 Mar; 35(1):33-8. PubMed ID: 17411349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.
    Vignati L; Turlizzi E; Monaci S; Grossi P; Kanter Rd; Monshouwer M
    Toxicology; 2005 Dec; 216(2-3):154-67. PubMed ID: 16169652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and intralaboratory evaluation of an in vitro human cell-based test to aid ocular irritancy assessments.
    Osborne R; Perkins MA; Roberts DA
    Fundam Appl Toxicol; 1995 Nov; 28(1):139-53. PubMed ID: 8566478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
    Dent MP
    Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TestSmart-high production volume chemicals: an approach to implementing alternatives into regulatory toxicology.
    Green S; Goldberg A; Zurlo J
    Toxicol Sci; 2001 Sep; 63(1):6-14. PubMed ID: 11509738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-line monitoring of cell growth and cytotoxicity using electric cell-substrate impedance sensing (ECIS).
    Xiao C; Luong JH
    Biotechnol Prog; 2003; 19(3):1000-5. PubMed ID: 12790667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro toxicity testing with microplate cell cultures: Impact of cell binding.
    Gülden M; Schreiner J; Seibert H
    Toxicology; 2015 Jun; 332():41-51. PubMed ID: 24291469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The FRAME alternatives laboratory database. 1. In vitro basal cytotoxicity determined by the Kenacid blue total protein assay.
    Clothier R; Gottschalg E; Casati S; Balls M
    Altern Lab Anim; 2006 May; 34(2):151-75. PubMed ID: 16704290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.